Rep. Jared Moskowitz Purchases Shares of McKesson Co. (NYSE:MCK)

Representative Jared Moskowitz (D-Florida) recently bought shares of McKesson Co. (NYSE:MCK). In a filing disclosed on February 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in McKesson stock on January 15th. The trade occurred in the Representative’s “MORGAN STANLEY ACTIVE ASSETS (5)” account.

Representative Jared Moskowitz also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of AbbVie (NYSE:ABBV) on 1/15/2025.
• Sold $1,001 – $15,000 in shares of Canadian National Railway (NYSE:CNI) on 1/15/2025.
• Purchased $1,001 – $15,000 in shares of Stryker (NYSE:SYK) on 1/15/2025.
• Purchased $1,001 – $15,000 in shares of The Goldman Sachs Group (NYSE:GS) on 1/15/2025.
• Sold $1,001 – $15,000 in shares of Merck & Co., Inc. (NYSE:MRK) on 1/15/2025.
• Sold $1,001 – $15,000 in shares of Abbott Laboratories (NYSE:ABT) on 1/15/2025.

McKesson Trading Up 1.2 %

MCK opened at $610.57 on Wednesday. The company has a market cap of $77.51 billion, a price-to-earnings ratio of 27.96, a price-to-earnings-growth ratio of 1.30 and a beta of 0.52. The stock has a fifty day simple moving average of $588.04 and a two-hundred day simple moving average of $562.60. McKesson Co. has a 12-month low of $464.42 and a 12-month high of $637.51.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. On average, analysts predict that McKesson Co. will post 32.69 EPS for the current year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Monday, March 3rd will be given a dividend of $0.71 per share. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $2.84 annualized dividend and a dividend yield of 0.47%. McKesson’s dividend payout ratio is presently 13.00%.

Institutional Trading of McKesson

Several hedge funds have recently bought and sold shares of the stock. Signature Estate & Investment Advisors LLC raised its position in shares of McKesson by 0.7% during the 4th quarter. Signature Estate & Investment Advisors LLC now owns 103,253 shares of the company’s stock valued at $58,845,000 after purchasing an additional 683 shares during the period. TIAA Trust National Association raised its holdings in McKesson by 2.1% during the fourth quarter. TIAA Trust National Association now owns 7,966 shares of the company’s stock valued at $4,540,000 after acquiring an additional 166 shares during the period. Princeton Capital Management LLC lifted its position in shares of McKesson by 6.2% in the fourth quarter. Princeton Capital Management LLC now owns 723 shares of the company’s stock valued at $412,000 after acquiring an additional 42 shares in the last quarter. Modern Wealth Management LLC boosted its stake in shares of McKesson by 80.3% in the fourth quarter. Modern Wealth Management LLC now owns 795 shares of the company’s stock worth $480,000 after acquiring an additional 354 shares during the period. Finally, Segall Bryant & Hamill LLC grew its position in shares of McKesson by 25.5% during the fourth quarter. Segall Bryant & Hamill LLC now owns 81,223 shares of the company’s stock worth $46,290,000 after purchasing an additional 16,502 shares in the last quarter. Institutional investors own 85.07% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on MCK. Baird R W raised McKesson from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 7th. Bank of America cut their target price on McKesson from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Mizuho started coverage on McKesson in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $630.00 price target for the company. Evercore ISI increased their price objective on shares of McKesson from $650.00 to $675.00 and gave the company an “outperform” rating in a research report on Thursday, February 6th. Finally, Citigroup decreased their target price on shares of McKesson from $713.00 to $677.00 and set a “buy” rating for the company in a report on Friday, January 10th. Two investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, McKesson has a consensus rating of “Buy” and a consensus price target of $645.79.

Insider Activity at McKesson

In other news, EVP Leann B. Smith sold 579 shares of the firm’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $602.81, for a total transaction of $349,026.99. Following the completion of the transaction, the executive vice president now owns 1,443 shares in the company, valued at $869,854.83. This trade represents a 28.64 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.11% of the stock is owned by corporate insiders.

About Representative Moskowitz

Jared Evan Moskowitz (Democratic Party) is a member of the U.S. House, representing Florida’s 23rd Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Moskowitz (Democratic Party) is running for re-election to the U.S. House to represent Florida’s 23rd Congressional District. He declared candidacy for the 2026 election.

Jared Evan Moskowitz was born in Coral Springs, Florida. Moskowitz graduated from Marjory Stoneman Douglas High School. He earned a bachelor’s degree in political science and government from George Washington University in 2003 and a law degree from Nova Southeastern University in 2007. Moskowitz’s career experience includes working as the director of the Florida Division of Emergency Management and general counsel with AshBritt Inc.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.